Book a demo

Cut patent&paper research from weeks to hours with PatSnap Eureka AI!

Try now

Exoskeleton patent landscape 2026: AI and modularity

Exoskeleton Technology Landscape 2026 — PatSnap Insights
Innovation Intelligence

Exoskeleton technology is undergoing a rapid transition from clinical prototypes to commercially deployable platforms. Converging advances in AI-driven motion planning, modular hardware architectures, and networked rehabilitation management are driving a new generation of systems that are smarter, lighter, and more broadly applicable — with China, Europe, and the United States each staking distinct positions in the global patent landscape.

PatSnap Insights Team Innovation Intelligence Analysts 11 min read
Share
Reviewed by the PatSnap Insights editorial team ·

Innovation Timeline & Technology Maturity

Exoskeleton patent activity spans more than two decades, with the earliest filings in this dataset dating to 2003–2004, when the European Space Agency established cable-tendon actuation and six-degree-of-freedom kinematic chains as foundational upper-limb wearable robotics concepts. From that baseline, the field has passed through three identifiable phases of development that are visible in the filing record.

2003
Earliest filings in dataset (ESA, FR)
20+
Chinese-origin records in dataset
6+
Wandercraft patents (2021–2025)
5
Emerging technology directions (2024–2026)

A mid-stage cluster emerged between 2011 and 2018, reflecting growing commercialization interest. Notable entries include cable-driven arm exoskeletons from Universidad Politécnica de Madrid, early lower-limb rehabilitation platforms from Ekso Bionics, and the first modular lower-limb exoskeleton architecture from CSIC (Spain’s National Research Council). The ExoAtlet lower-limb system and Vanderbilt University gravity-compensation control similarly populate this maturation window.

The most recent filing cluster (2021–2026) is the most populous in this dataset and signals active innovation on three fronts: deep learning and neural network trajectory planning (Wandercraft, FR/JP/CN/CA, 2021–2025); real-time feedback-based adaptive control (Dephy, Inc., US/CA/EP, 2021–2025); and AI-integrated performance analysis and simulation tooling (ETRI, KR, 2026; University of Electronic Science and Technology of China, CN, 2024). The Boston Dynamics perception system patent (WO, 2024) and the CSIC modular autonomous exoskeleton update (EP, 2024) indicate the frontier is moving toward sensor-fused, autonomously coordinated platforms.

Figure 1 — Exoskeleton Patent Filing Activity by Era (2003–2026)
Exoskeleton patent filing activity by era: early foundations (2003–2010), mid-stage commercialisation (2011–2018), and the 2021–2026 AI-driven cluster 0 5 10 15 Relative filing volume Low 2003–2010 Foundations Medium 2011–2018 Commercialisation Highest 2021–2026 AI-Driven Growth Early Foundations Mid-Stage AI-Driven Cluster
The 2021–2026 filing cluster is the most populous in the dataset, with active innovation in neural network trajectory planning, adaptive control, and AI-integrated simulation tooling — representing a step-change from earlier commercialisation-era filings.

The earliest exoskeleton patent filings in the 2026 PatSnap dataset date to 2003–2004, when the European Space Agency filed patents establishing cable-tendon actuation and six-degree-of-freedom kinematic chains as foundational upper-limb wearable robotics concepts.

Four Key Technology Clusters Shaping the Field

Four distinct innovation clusters define the current exoskeleton technology landscape, each with a different lead assignee, control philosophy, and competitive dynamic. Understanding these clusters is essential for any freedom-to-operate analysis or R&D positioning exercise.

Cluster 1: Neural Network & AI-Based Trajectory Planning

This is the most active innovation cluster in the dataset, dominated by Wandercraft (France). The approach trains hierarchical neural networks — first on periodic elementary gait trajectories, then on transition sequences between gaits — to enable autonomous, human-unassisted bipedal locomotion across varied terrain. The architecture addresses the fundamental instability problem of underactuated exoskeletons without requiring crutch stabilization. Wandercraft has filed at least 6 patent records across FR, JP, CN, and CA jurisdictions between 2021 and 2025, making it the most prolific single exoskeleton assignee in the dataset.

Complementary AI-driven control approaches appear from Chinese institutions: Tongji University’s large-model-based intent trajectory planning (CN, 2024) integrates visual segmentation models with inertial sensors to simultaneously satisfy wearer intent and obstacle avoidance constraints. The State Grid Shanxi Electric Power Research Institute (CN, 2025) applies AI parameter learning specifically to dynamic power motor output adjustment across motion scenarios.

“Fixed-trajectory exoskeletons without adaptive AI control will face rapid obsolescence in both clinical and industrial markets — neural network trajectory generation, real-time collaboration metrics, and large-model intent planning collectively signal this shift.”

Cluster 2: Real-Time Adaptive Control & Biometric Collaboration Metrics

Dephy, Inc. (US/CA/EP) is the primary assignee in this cluster. The core innovation is a user-exoskeleton collaboration metric computed from simultaneous biometric monitoring of the wearer and mechanical parameter sensing of the exoskeleton boot, enabling real-time optimization of assistive force levels without predefined gait templates. Dephy’s fully adaptive approach, visible in filings from 2021 (US) through 2025 (EP), represents a significant advance over the predefined-but-user-adjustable trajectory control paradigms used by earlier systems such as ExoAtlet and CEA.

What is a biometric collaboration metric?

In Dephy’s architecture, a collaboration metric is computed in real time from simultaneous biometric data (from the wearer’s body) and mechanical parameter data (from the exoskeleton device). This metric drives continuous optimization of assistive force levels — eliminating the need for pre-programmed gait templates and enabling the system to adapt dynamically to each user’s movement patterns.

Cluster 3: Modular Autonomous Architecture

CSIC (Spain’s National Research Council) has filed a distinctive architecture in which each joint module carries a dedicated controller, communicates via a multimaster bus, determines the presence of neighboring modules autonomously, and calculates its own trajectory while coordinating with joint-kinematic data from peer modules. This distributed control approach eliminates a central controller as a single point of failure and supports easy configuration reconfiguration — covering knee-only, hip+knee, or full lower-limb configurations from the same hardware base. CSIC’s EP filings span 2016 through 2024, with limited direct competition visible in the dataset, representing a potential IP white space for entrants designing for configurability.

Cluster 4: Sensing, Perception & Human Intent Detection

This cluster addresses how exoskeletons interpret wearer intent and environmental context. The Shenzhen Institutes of Advanced Technology (Chinese Academy of Sciences) developed vision-based footstep planning with holographic display output (CN, 2021–2022), using terrain stereo mapping and intent capture from limb gestures or voice. Boston Dynamics has more recently filed a camera-based terrain perception system for lower-body powered exoskeletons with footstep planning integrated in the control loop (WO, 2024). Hangzhou Cheng Tian Technology (CN, 2019) combines plantar pressure, joint encoders, force/torque sensors, IMUs, and non-contact capacitive EMG sensors into a CNN-based full-intent detection system. According to IEEE standards for robotic systems, multi-modal sensor fusion of this type is increasingly considered a prerequisite for safe human-robot interaction.

Explore the full patent landscape for exoskeleton sensing and AI control in PatSnap Eureka.

Explore Patent Data in PatSnap Eureka →

Wandercraft (France) is the most prolific single exoskeleton patent assignee in the 2026 PatSnap dataset, with at least 6 patent records across FR, JP, CN, and CA jurisdictions filed between 2021 and 2025, all focused on hierarchical neural network trajectory planning for autonomous bipedal locomotion.

Geographic & Assignee Landscape: Who Leads Where

China is the dominant jurisdiction by filing count in this dataset, with more than 20 distinct Chinese-origin records spanning the full technology stack. Europe and the United States each hold distinct positions defined by a smaller number of highly active assignees, while Korea signals growing institutional investment through recent ETRI filings.

Figure 2 — Exoskeleton Patent Filing Concentration by Geography (Relative Share in Dataset)
Exoskeleton patent filing concentration by geography in the 2026 PatSnap dataset: China leads with more than 20 records, followed by Europe, United States, and Korea 0 5 10 15 20+ 20+ China (CN) ~12 Europe (EP/ES/FR) ~6 United States ~2 Korea (KR) Records in dataset
China accounts for more than 20 distinct records in this dataset — the highest volume of any single jurisdiction — spanning mechanical design, AI control, simulation tooling, and reliability analysis. Europe leads in rehabilitation and autonomous locomotion control.

The geographic breakdown reveals distinct strategic postures. China is building the deepest supply-side ecosystem, with institutional researchers (Chinese Academy of Sciences Shenzhen Institute, Tongji University, Harbin Institute of Technology, University of Electronic Science and Technology of China, Zhejiang University, Northeast University) and commercial entities (Nanjing Weisi Medical Technology, Maibo Intelligent Technology) collectively covering every layer of the stack. Europe is concentrated in rehabilitation and autonomous locomotion, with Wandercraft’s neural trajectory work and CSIC’s modular architecture as the headline contributions. The United States is commercially focused: Ekso Bionics targets clinical gait therapy, Dephy targets adaptive assistive footwear, and Boston Dynamics (WO, 2024) signals interest in outdoor-capable powered exoskeletons. Korea‘s ETRI filings from 2025–2026 on AI-based control logic assessment and performance prediction represent a notable institutional commitment that may signal broader Korean investment ahead, consistent with broader trends in robotics R&D tracked by OECD.

Innovation is moderately concentrated: Wandercraft, Ekso Bionics, CSIC, and the Shenzhen Advanced Technology Institute account for the majority of substantive claims, while Chinese institutions collectively represent the broadest coverage. Foreign entrants targeting Chinese markets should assess freedom-to-operate across this dense filing cluster before committing to hardware configurations — a process that can be accelerated through PatSnap’s IP intelligence platform.

China (CN) is the most prolific exoskeleton patent jurisdiction in the 2026 PatSnap dataset, with more than 20 distinct Chinese-origin records from institutions including the Chinese Academy of Sciences Shenzhen Institute, Tongji University, Harbin Institute of Technology, and commercial entities such as Nanjing Weisi Medical Technology and Maibo Intelligent Technology.

Application Domains: From Rehabilitation to Industrial Use

Medical rehabilitation is the most heavily populated application domain in the dataset, covering spinal cord injury recovery, stroke gait rehabilitation, and elderly mobility assistance — but industrial, military, and simulation-tooling applications are each growing in distinct ways.

Medical Rehabilitation

Key innovators in rehabilitation include Ekso Bionics (US), which has developed machine-to-human ready-feedback interfaces and coordinated therapy modes including gait-prep, balance training, and center-of-pressure prompting. ExoAtlet (Russia) offers predefined-trajectory lower-limb devices with user-adjustable gait parameters for paraplegic users. Ferdowsi University of Mashhad (Iran) has developed a two-phase rehabilitation exoskeleton that moves from cane-assisted predefined trajectory to user-balance-controlled assistance. National Chung Hsing University (Taiwan) has filed a combined upper/lower-limb rehabilitation exoskeleton integrating VR/AR environments, pneumatic muscle dynamic body-weight support, and eye-tracking task initiation. Roam Robotics (US, via CN filing, 2023) adds a networked dimension — configuring treatment protocols across an exoskeleton network by receiving usage data from multiple deployed units and remotely pushing updated therapy configurations, a model validated by clinical outcome research published through NIH.

Industrial Load Augmentation & Worker Safety

Passive and semi-active industrial exoskeletons appear in filings from Tata Consultancy Services (IN, 2024), which proposes a biomechanical design optimization framework using motion capture data from realistic industrial tasks — lifting, overhead assembly — to minimize muscle effort. Chengdu Jinjiang Electronic System Engineering (CN, 2020) explicitly targets military and load-bearing civilian use. The ROS-based simulation control system from Maibo Intelligent Technology (CN, 2024) specifically references heavy-labor assistance and emergency rescue as target scenarios.

Key finding: Industrial filings use different claim language

Recent industrial and military exoskeleton filings from Harbin Institute of Technology (CN, 2025) and Tata Consultancy Services (IN, 2024) increasingly reference ergonomic optimization and fatigue prevention rather than medical treatment. This language shift may place these products in different regulatory pathways and open faster routes to market compared with medical device classifications.

Military & Defense

Several lower-limb designs explicitly cite military load-carrying as a primary use case, including the Chengdu Jinjiang system (CN, 2020), the Harbin Institute of Technology (Shenzhen) underactuated walking system (CN, 2025), and the Universidad Politécnica de Madrid arm exoskeleton (ES, 2011–2016), which lists fire, police, and military force augmentation among intended applications.

Simulation & Digital Development Tooling

A growing application domain is the exoskeleton development environment itself. Nanjing Weisi Medical Technology (CN, 2023) developed a CoppeliaSim-based hardware-in-the-loop simulation system. The University of Electronic Science and Technology of China (CN, 2024) built a bidirectional physical human-machine interaction simulation with real-time synchronization. Northeast University (CN, 2025) created a Matlab-OpenSim joint simulation platform with multi-algorithm support covering PID, fuzzy PID, and sliding-mode control. ETRI (KR, 2026) is developing AI model-based exoskeleton performance prediction using sensor data from deployed wearable devices. This proliferation suggests simulation software will be a revenue-generating layer independent of hardware sales — and a defensive IP position in this area may be undervalued.

Map competitive white space across exoskeleton application domains using PatSnap Eureka’s AI-powered patent analysis.

Analyse Exoskeleton Patents in PatSnap Eureka →

Five Emerging Directions in Exoskeleton Innovation (2024–2026)

The most recent filings in this dataset (2024–2026) reveal five clear directional signals that will shape the next competitive cycle in exoskeleton technology — moving the field from task-specific devices toward intelligent, connected, and predictively maintained platforms.

Figure 3 — Five Emerging Exoskeleton Innovation Directions (2024–2026)
Five emerging exoskeleton technology directions from 2024 to 2026 patent filings: large foundation models, AI performance prediction, terrain-aware perception, passive biomechanical optimisation, and networked therapy platforms Large Foundation Models Tongji Univ. CN 2024 AI Perf. Prediction ETRI KR 2025–2026 Terrain Perception Boston Dyn. WO 2024 Passive Biomech. Optim. Tata TCS IN 2024 Networked Therapy Platforms Roam Robotics CN 2023
Five directional signals from 2024–2026 patent filings map the next competitive cycle: from large-model intent planning and predictive maintenance through to SaaS-style networked therapy management.

1. Large Foundation Model Integration for Intent Planning. Tongji University (CN, 2024) applies vision foundation models — real-time image segmentation — combined with inertial sensors to generate exoskeleton intent trajectories that jointly satisfy user motion preference and obstacle avoidance constraints. This represents the first generation of exoskeleton control architectures that leverage large-scale pretrained vision-language models rather than task-specific classifiers.

2. AI-Based Performance Prediction and Lifecycle Management. ETRI’s 2025–2026 filings introduce AI models trained on wearable sensor data to predict exoskeleton joint and system performance degradation over time, enabling predictive maintenance and clinically meaningful outcome tracking.

3. Terrain-Aware Perception Systems for Powered Lower-Limb Exoskeletons. Boston Dynamics’ 2024 WO filing adds camera-based terrain sensing and footstep planning as a standard functional block for lower-body powered exoskeletons, suggesting this will become a baseline capability requirement for outdoor-capable systems.

4. Passive Exoskeleton Biomechanical Optimization for Industrial Use. Tata Consultancy Services (IN, 2024) is developing systematic optimization frameworks that use motion-capture-derived muscle force and joint torque data across realistic industrial tasks to configure passive exoskeleton spring parameters — bringing engineering rigor to a domain that has historically relied on empirical lab testing.

5. Networked Exoskeleton Therapy Platforms. Roam Robotics (US, via CN filing, 2023) has introduced network-connected exoskeleton fleets where therapy protocols are dynamically configured or updated remotely across multiple concurrently deployed devices, pointing toward a SaaS-style clinical management layer atop the physical hardware. This model aligns with broader digital health platform trends documented by WHO in its digital health strategy frameworks.

ETRI (Korea Electronics and Telecommunications Research Institute) filed patents in 2025 and 2026 introducing AI models trained on wearable sensor data to predict exoskeleton joint and system performance degradation over time, enabling predictive maintenance for deployed exoskeleton devices.

Strategic Implications for R&D and IP Teams

The patent landscape described in this dataset yields five actionable strategic signals for R&D leaders, IP counsel, and innovation strategists working in or adjacent to exoskeleton technology.

AI integration is now table stakes for competitive differentiation. Neural network trajectory generation (Wandercraft), real-time collaboration metrics (Dephy), and large-model intent planning (Tongji University) collectively suggest that fixed-trajectory exoskeletons without adaptive AI control will face rapid obsolescence in both clinical and industrial markets. R&D investment should prioritize model-based or learning-based control from the architecture stage.

Modular, distributed control architectures offer IP white space. CSIC’s multimaster module-per-joint paradigm (EP, 2022–2024) is a differentiated position with limited direct competition visible in this dataset. Entrants designing for configurability — knee-only vs. hip+knee vs. full lower limb — should examine this space carefully for both freedom-to-operate analysis and potential licensing. Patent landscaping tools from PatSnap can accelerate this analysis significantly.

China is building the deepest supply-side ecosystem. With the highest filing volume across mechanical design, AI control, simulation tooling, and reliability analysis, Chinese entities are positioned to commercialize at scale. Foreign entrants targeting Chinese markets should assess freedom-to-operate across this dense filing cluster before committing to hardware configurations.

Simulation and digital development platforms are becoming a distinct product category. The proliferation of hardware-in-the-loop frameworks, human-exoskeleton co-simulation environments, and AI model performance testing systems (CN, KR, 2023–2026) indicates that simulation software will be a revenue-generating layer independent of hardware sales — and a defensive IP position in this area may be undervalued.

Clinical rehabilitation remains the dominant application but industrial and military use cases are growing. IP strategists should note that claim language in recent industrial and military filings increasingly references ergonomic optimization and fatigue prevention rather than medical treatment, potentially placing these products in different regulatory pathways and opening faster routes to market. This distinction is increasingly relevant as wearable robotics standards bodies, including those affiliated with ISO, develop separate classification frameworks for occupational versus medical exoskeleton devices.

CSIC (Spain’s National Research Council) has filed a modular exoskeleton architecture (EP, 2022–2024) in which each joint module carries a dedicated controller communicating via a multimaster bus, with limited direct competition visible in the 2026 PatSnap dataset — representing a potential IP white space for entrants designing configurable exoskeleton systems.

Frequently asked questions

Exoskeleton Technology Landscape 2026 — key questions answered

Still have questions? Let PatSnap Eureka answer them for you.

Ask PatSnap Eureka for a Deeper Answer →

References

  1. Machine-to-human interfaces for communication from a lower limb orthosis — Ekso Bionics, Inc., 2022, ES
  2. Ambulatory exoskeleton: procedure for controlling an ambulatory exoskeleton — CEA, 2022, ES
  3. Methods for learning neural network parameters, generating exoskeleton trajectories, and moving exoskeletons — Wandercraft, 2022, JP
  4. Methods for learning parameters of a neural network, generating a trajectory for an exoskeleton, and setting the exoskeleton in motion — Wandercraft, 2021, FR
  5. Methods for learning parameters of a neural network, generating a trajectory for an exoskeleton, and setting the exoskeleton in motion — Wandercraft, 2024, CA
  6. Real-time feedback-based optimization of an exoskeleton — Dephy, Inc., 2021, US
  7. Real-time feedback-based optimization of an exoskeleton — Dephy, Inc., 2025, EP
  8. Exoskeleton comprising a plurality of autonomously operable modules — CSIC, 2022, EP
  9. Exoskeleton comprising a plurality of autonomously operable modules — CSIC, 2024, EP
  10. Perception system for a lower body powered exoskeleton — Boston Dynamics, Inc., 2024, WO
  11. Vision-based exoskeleton robot footstep planning system, method and storage medium — Shenzhen Institutes of Advanced Technology, CAS, 2022, CN
  12. An exoskeleton robot and detection method for detecting human motion intent — Hangzhou Cheng Tian Technology, 2019, CN
  13. Exoskeleton system for rehabilitation training in collaboration between upper limb and lower limb on the basis of VR and AR — National Chung Hsing University, 2021, TW
  14. Exoskeleton robot for rehabilitation of spinal cord injury patients — Ferdowsi University of Mashhad, 2020, IR
  15. Exoskeleton — ExoAtlet LLC, 2020, EP
  16. System and method for biomechanical design optimization of passive exoskeleton — Tata Consultancy Services Limited, 2024, IN
  17. System and method for analyzing performance of exoskeleton using artificial intelligence model — ETRI, 2026, KR
  18. Exoskeleton control logic assessment method and system — ETRI, 2025, KR
  19. Large-model-based walking exoskeleton intent trajectory planning method and system — Tongji University, 2024, CN
  20. Method for improving user mobility and therapy — Roam Robotics, 2023, CN
  21. IEEE — Standards and publications on robotic systems and human-robot interaction
  22. OECD — Science, Technology and Innovation Outlook: robotics and automation R&D investment trends
  23. NIH — National Institutes of Health: clinical outcome research in rehabilitation robotics
  24. WHO — Digital Health Strategy: networked health technology platform frameworks
  25. ISO — International standards for exoskeleton and wearable robotic device classification

All data and statistics in this article are sourced from the references above and from PatSnap‘s proprietary innovation intelligence platform. This landscape is derived from a limited set of patent and literature records retrieved across targeted searches and represents a snapshot of innovation signals within this dataset only — it should not be interpreted as a comprehensive view of the full industry.

Your Agentic AI Partner
for Smarter Innovation

PatSnap fuses the world’s largest proprietary innovation dataset with cutting-edge AI to
supercharge R&D, IP strategy, materials science, and drug discovery.

Book a demo